BusinessVeritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto RicoBy Nasdaq OMXDec 5, 2017, 8:05 AM UTC
BusinessVeritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory BoardBy Nasdaq OMXNov 29, 2017, 9:30 PM UTC
BusinessUS Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm CannevertBy Nasdaq OMXNov 28, 2017, 8:05 AM UTC
BusinessCannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UKBy Nasdaq OMXNov 22, 2017, 9:15 PM UTC
BusinessVeritas’ Research Arm Cannevert Therapeutics Signs Letter of Intent with Fundación de Investigación (FDI) of Puerto Rico USA to Begin Human Trials of Its Lead Cannabis Strain for PainBy Nasdaq OMXNov 20, 2017, 8:05 AM UTC
BusinessVeritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing FacilityBy Nasdaq OMXNov 18, 2017, 9:44 PM UTC
BusinessVeritas Pharma Initiates Cancer Research with Dr. Dmitri PetchkovskiBy Nasdaq OMXNov 14, 2017, 9:15 PM UTC
BusinessA Provisional Patent Application for Use of Specific Cannabis Strain in Neuropathic Pain Filed With the US Patent OfficeBy Nasdaq OMXNov 7, 2017, 9:00 AM UTC
